Skip to main content
OpenTrials
Completed

NCT Number: NCT01927822

Factors Influencing the Abortion Interval of Second-trimester Termination of Pregnancy Using Misoprostol

This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Labor Induction

Age range

13 year–50 year

Sex eligibility

Female

Study type

Observational

Primary location

Far Eastern Memorial Hospital

New Taipei, Taiwan, 220

About this study

Misoprostol is the primary drug of choice for medical termination. It is not only cheap, but also stable at room temperature and easily available worldwide. It is indicated for the treatment of gastritis, but is widely used off-label for a variety of indications in the practice of obstetrics and gynecology, including medication abortion, induction of labor, and the treatment of postpartum hemorrhage. The optimal dosage and route of administration have not been well defined and vary with physicians. The potency of misoprostol's effect varies with dosage, route of administration and dosing interval; both maternal and fetal factors may, to certain extent, affect the abortion interval. This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

1.All female patients who were admitted for medical termination of second-trimester pregnancy

Exclusion criteria

  • Patients who are allergy to Cytotec.

Treatment and study plan

Primary outcomes

  1. Successful termination rate by Cytotec.

    Time frame: 1 week

Secondary outcomes

  1. Factors affecting abortion interval by cytotec.

    Time frame: 1 week

    To identify the factors affecting termination interval Cox regression model.

Sponsors and collaborators

Lead sponsor

Far Eastern Memorial Hospital

Other

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Aug 23, 2013
Registry last updated
Jul 7, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.